| Literature DB >> 26437614 |
A P Duarte de Souza1,2,3, D Nascimento de Freitas1,2,3, K E Antuntes Fernandes1,2,3, M D'Avila da Cunha1,2,3, J L Antunes Fernandes1,2,3, R Benetti Gassen1,2,3, T Fazolo1,2,3, L A Pinto4,2,3, M Scotta4,2,3, R Mattiello4,2,3, P M Pitrez4,2,3, C Bonorino5,3, R T Stein4,2,3.
Abstract
Respiratory syncytial virus (RSV)-specific CD8(+) T cell responses do not protect against reinfection. Activation of mammalian target of rapamycin (mTOR) impairs memory CD8(+) T cell differentiation. Our hypothesis was that RSV inhibits the formation of CD8(+) T cells memory responses through mTOR activation. To explore this, human and mouse T cells were used. RSV induced mTOR phosphorylation at Ser2448 in CD8 T cells. mTOR activation by RSV was completely inhibited using rapamycin. RSV-infected children presented higher mTOR gene expression on nasal washes comparing to children infected with metapneumovirus and rhinovirus. In addition, RSV-infected infants presented a higher frequency of CD8(+) pmTORser2448(+) T cells in nasal washes compared to RSV-negative infants. Rapamycin treatment increased the frequency of mouse CD8 RSV-M282-90 pentamer-positive T cells and the frequency of RSV-specific memory T cells precursors. These data demonstrate that RSV is activating mTOR directly in CD8 T cells, indicating a role for mTOR during the course of RSV infection.Entities:
Keywords: CD8+ T cells; RSV; RSV-infected infants; mTOR; nasal washes
Mesh:
Substances:
Year: 2015 PMID: 26437614 PMCID: PMC4711155 DOI: 10.1111/cei.12720
Source DB: PubMed Journal: Clin Exp Immunol ISSN: 0009-9104 Impact factor: 4.330